Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Tuberous Sclerosis 2Vascular Malformations 1Triple Negative Breast Neoplasms 1Peutz-Jeghers Syndrome 1Perivascular Epithelioid Cell Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1Malignant Solid Tumors 1Lymphangioma 1Lymphangioleiomyomatosis 1Leiomyoma 1Kaposiform Hemangioendothelioma 1Hereditary Sensory and Autonomic Neuropathies 1Hematologic Neoplasms 1Hemangioendothelioma 1Graft vs Host Disease 1Epilepsy 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Advanced Solid Tumors 1

Interventions

Injections 4Paclitaxel 2toripalimab 1tesetaxel 1sintilimab 1satraplatin 1pembrolizumab 1liposomal doxorubicin 1isophosphamide mustard 1fluzoparib 1duvelisib 1camrelizumab 1apatinib 1anlotinib 1Vinorelbine 1Sirolimus 1Saline Solution 1SKLB1028 1Radiotherapy 1Panobinostat 1Lenalidomide 1Irinotecan 1Everolimus 1Docetaxel 1Carboplatin 1Biomarkers 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Advanced Solid Tumors × Sirolimus × Clear all
NCT05125523 2022-01-25

A Study of Sirolimus for Injection (Albumin Bound) in Patients With Advanced Solid Tumors

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Phase 1 Unknown
264 enrolled
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡